Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

OBJECTIVE: To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from natalizumab to fingolimod. METHODS: In this multicenter, double-blind, placebo-controlled trial (TOFINGO), patients with relapsing-remittin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501941/
https://www.ncbi.nlm.nih.gov/pubmed/26024899
http://dx.doi.org/10.1212/WNL.0000000000001706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501941/
https://www.ncbi.nlm.nih.gov/pubmed/26024899
http://dx.doi.org/10.1212/WNL.0000000000001706

Ejemplares similares